A service of arranging or bringing about contact between an investment manager and an issuer or potential issuer.
Initial Shipment of 2-10 Minute COVID-19 Rapid Tests Received at Company's Englewood, Colorado Facility ENGLEWOOD, CO / April 1, 2020 / Aytu BioScience, Inc. (NASDAQ:AYTU),(the "Company"), a specialty pharmaceutical company focused on commercializing novel products...
ENGLEWOOD, CO / March 30, 2020 / Aytu BioScience, Inc. (NASDAQ:AYTU) (the "Company"), a specialty pharmaceutical company focused on commercializing novel products that address significant patient needs, announced today that its annual meeting of stockholders...
ENGLEWOOD, CO / March 25, 2020 / Aytu BioScience, Inc. (NASDAQ:AYTU) (the "Company"), a specialty pharmaceutical company focused on commercializing novel products that address significant patient needs, announced that it received notice from The Nasdaq Stock Market,...
Commercial Distribution of First 100,000 Tests to Commence Upon Receipt of Inbound Product Shipment ENGLEWOOD, CO / March 23, 2020 / Aytu BioScience, Inc. (NASDAQ:AYTU), a specialty pharmaceutical company focused on commercializing novel products that address...
ENGLEWOOD, CO / March 19, 2020 / Aytu BioScience, Inc. (NASDAQ:AYTU), a specialty pharmaceutical company focused on commercializing novel products that address significant patient needs, today announced that it has entered into definitive agreements with several...
Company Expects to Seek Regulatory Clearance Under Health Canada and COFEPRIS Expedited Clearance Procedures ENGLEWOOD, CO / March 19, 2020 / Aytu BioScience, Inc. (NASDAQ:AYTU), a specialty pharmaceutical company focused on commercializing novel products that address...
Updated FDA Policy Likely Enables Near-Term Availability of COVID-19 Test in the U.S. ENGLEWOOD, CO / March 17, 2020 / Aytu BioScience, Inc. (NASDAQ:AYTU), a specialty pharmaceutical company focused on commercializing novel products that address significant patient...
ENGLEWOOD, CO / March 16, 2020 / Aytu BioScience, Inc. (NASDAQ:AYTU), a specialty pharmaceutical company focused on commercializing novel products that address significant patient needs announced today it was featured on a FOX segment titled: "Englewood company says...
Healthcare professionals, institutions, and other interested parties with questions about the Company's recently licensed COVID-19 IgG/IgM Rapid Test are asked to send email inquiries to COVID-19@aytubio.com ENGLEWOOD, CO / March 13, 2020 / Aytu BioScience, Inc....
ENGLEWOOD, CO / March 12, 2020 / Aytu BioScience, Inc. (NASDAQ:AYTU), a specialty pharmaceutical company focused on commercializing novel products that address significant patient needs, today announced that it has entered into definitive agreements with several...